Literature DB >> 28321376

Role of Glioblastoma Craniotomy Related to Patient Survival: A 10-Year Survey in a Tertiary Care Hospital in Pakistan.

Saman Shahid1, Kamran Hussain2.   

Abstract

A total of 270 glioblastoma patients were treated for tumor resection during 2004 to 2014. The following variables were examined: patient age group (PAG) and percent of the extent of resection (EOR) in four types of resections: gross total resection (GTR), subtotal resection (STR), partial resection (PR), and biopsy/decompression (BD). The Karnofsky performance scale (KPS) was used and the average survival time noted. The least survival time (7 months) was noticed in the patient age group 18 to 35 years with biopsy only, whereas, the maximum survival time (14.5 months) was noted with the patient age group 54 to 71 years by gross tumor resection. The largest number of (n = 76) patients had PR (80%) and these patients had an average survival time of 10.5 months. Total 190 patients out of 270, with EOR (100-80%) had a KPS score "0" (80 and above) and total 80 patients out of 270 patients, with EOR (50%) had a KPS score "1" (below 80). The correlation was statistically significant at (p < 0.050) for EOR (%) and KPS score (0/1) only. Correlation analysis showed that the maximum resection has a strong impact on the glioblastoma patient's survival. A lesser EOR correlated with poor quality of life and also a decreased survival of patients.

Entities:  

Keywords:  craniotomy; extent of resection; glioblastoma; patient survival; quality of life

Year:  2016        PMID: 28321376      PMCID: PMC5357222          DOI: 10.1055/s-0036-1593469

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  23 in total

Review 1.  Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors.

Authors:  R Sawaya; M Hammoud; D Schoppa; K R Hess; S Z Wu; W M Shi; D M Wildrick
Journal:  Neurosurgery       Date:  1998-05       Impact factor: 4.654

2.  The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients.

Authors:  C J Vecht; C J Avezaat; W L van Putten; W M Eijkenboom; S Z Stefanko
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-06       Impact factor: 10.154

3.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

4.  Radiation response and survival time in patients with glioblastoma multiforme.

Authors:  F G Barker; M D Prados; S M Chang; P H Gutin; K R Lamborn; D A Larson; M K Malec; M W McDermott; P K Sneed; W M Wara; C B Wilson
Journal:  J Neurosurg       Date:  1996-03       Impact factor: 5.115

5.  Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.

Authors:  Daniela Kuhnt; Andreas Becker; Oliver Ganslandt; Miriam Bauer; Michael Buchfelder; Christopher Nimsky
Journal:  Neuro Oncol       Date:  2011-09-12       Impact factor: 12.300

Review 6.  Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.

Authors:  Hiroko Ohgaki; Paul Kleihues
Journal:  J Neuropathol Exp Neurol       Date:  2005-06       Impact factor: 3.685

7.  Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.

Authors:  Orin Bloch; Seunggu J Han; Soonmee Cha; Matthew Z Sun; Manish K Aghi; Michael W McDermott; Mitchel S Berger; Andrew T Parsa
Journal:  J Neurosurg       Date:  2012-10-05       Impact factor: 5.115

8.  Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis.

Authors:  F K Albert; M Forsting; K Sartor; H P Adams; S Kunze
Journal:  Neurosurgery       Date:  1994-01       Impact factor: 4.654

9.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Authors:  Matthew J McGirt; Kaisorn L Chaichana; Muraya Gathinji; Frank J Attenello; Khoi Than; Alessandro Olivi; Jon D Weingart; Henry Brem; Alf Redo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

10.  IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group.

Authors:  Martin J van den Bent; Hendrikus J Dubbink; Yannick Marie; Alba A Brandes; Martin J B Taphoorn; Pieter Wesseling; Marc Frenay; Cees C Tijssen; Denis Lacombe; Ahmed Idbaih; Ronald van Marion; Johan M Kros; Winand N M Dinjens; Thierry Gorlia; Marc Sanson
Journal:  Clin Cancer Res       Date:  2010-02-16       Impact factor: 13.801

View more
  1 in total

1.  Comparison of Glioblastoma Outcomes in Two Geographically and Ethnically Distinct Patient Populations in Disparate Health Care Systems.

Authors:  Farhan A Mirza; Muhammad Waqas S Baqai; Ummey Hani; Maher Hulou; Muhammad Shahzad Shamim; Syed Ather Enam; Thomas Pittman
Journal:  Asian J Neurosurg       Date:  2022-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.